Form D · Biotechnology
CHAMPIONS ONCOLOGY, INC.
Hackensack, NJ · CIK 0000771856
Offering snapshot reported Mar 25, 2015 · SEC filing
- Reported sold
- $14M Offering amount: $14M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Mar 13, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 25, 2015 | Initial | $14,000,000 | No comparison | 11 | SEC filing |
| Dec 12, 2014 | Initial | $2,000,000 | No comparison | 2 | SEC filing |
| Feb 7, 2013 | Initial | $9,300,000 | No comparison | 7 | SEC filing |
| Feb 13, 2012 | Initial | $8,500 | No comparison | 1 | SEC filing |
| Apr 14, 2011 | Initial | $9,400,000 | No comparison | 13 | SEC filing |
| Apr 7, 2011 | Initial | $1 | No comparison | 1 | SEC filing |
| Nov 1, 2010 | Initial | $0 | No comparison | 2 | SEC filing |
| Jan 5, 2010 | Initial | $2,100,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $641K
- Finders' fees
- $0
- Form D file number
- 021-236631
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| MTS Securities, LLC | 104059 |
Source: Form D, filed Mar 25, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joel Ackerman | Director, Executive |
| Douglas D. Burkett, Ph.D. | Executive |
| Arthur Epker, Iii | Director |
| Gary Gemignani | Executive |
| James M. Martell | Director |
| James Mc Gorry | Executive |
| Daniel Mendelson | Director |
| David Miller | Executive |
| Ronnie Morris | Director, Executive |
| Ronnie Morris, M.D. | Director, Executive |
| Abba David Poliakoff | Director |
| Mark R. Schonau | Executive |
| David Sidranksky | Director |
| David Sidransky | Director |
| David Sidransky, M.D. | Director |
| Ana Stancic | Director |
| Scott Tobin | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
One University Plaza Suite 307
Hackensack, NJ, 07601
Hackensack, NJ, 07601